# EDGAR Filing Document

**Accession Number:** 0000946394
**File Stem:** 0001213900-25-059694
**Filing Date:** 2025-6
**Character Count:** 68140
**Document Hash:** cd9d43008c75b88b699b72a7243958ee
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-059694.hdr.sgml**: 20250630

**ACCESSION NUMBER**: 0001213900-25-059694

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250630

**DATE AS OF CHANGE**: 20250630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ellomay Capital Ltd.
- **CENTRAL INDEX KEY:** 0000946394
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRIC SERVICES [4911]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35284
- **FILM NUMBER:** 251092538

**BUSINESS ADDRESS:**
- **STREET 1:** 9 ROTHSCHILD BLVD.
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6688112
- **BUSINESS PHONE:** 011-972-3-797-1111

**MAIL ADDRESS:**
- **STREET 1:** 9 ROTHSCHILD BLVD.
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6688112

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NUR MACROPRINTERS LTD
- **DATE OF NAME CHANGE:** 19980331

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NUR ADVANCED TECHNOLOGIES LTD
- **DATE OF NAME CHANGE:** 19950607

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**Report of Foreign Private Issuer<br> Pursuant to Rule 13a-16 OR 15d-16<br> UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of June 2025

Commission File Number: 001-35284

<u>Ellomay Capital Ltd.</u>

(Translation of registrant's name into English)

<u>18 Rothschild Blvd., Tel Aviv 6688121, Israel</u>

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

THE IFRS FINANCIAL RESULTS INCLUDED IN EXHIBIT 99.1 OF THIS FORM 6-K ARE HEREBY INCORPORATED BY REFERENCE INTO THE REGISTRANT'S REGISTRATION STATEMENTS ON FORM F-3 (NOS. [333-199696](http://www.sec.gov/Archives/edgar/data/946394/000117891314003294/zk1415708.htm) AND [333-144171](http://www.sec.gov/Archives/edgar/data/946394/000117891307001303/zk73866.htm)) AND FORM S-8 (NOS. [333-187533](http://www.sec.gov/Archives/edgar/data/946394/000092189513000690/s809220_03262013.htm), [333-102288](http://www.sec.gov/Archives/edgar/data/946394/000106823802000356/forms-8nurdec02.htm) AND [333-92491](http://www.sec.gov/Archives/edgar/data/946394/000117891313000894/zk1312868.htm)), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.

This Report on Form 6-K of Ellomay Capital Ltd. consists of the following document, which is attached hereto and incorporated by reference herein:

Exhibit 99.1 [Press Release: "Ellomay Capital Reports Results for the Three Months Ended March 31, 2025," dated June 30, 2025](ea024749301ex99-1_ellomay.htm).

**Signatures**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| Ellomay Capital Ltd. | Ellomay Capital Ltd. |
| By: | */s/ Ran Fridrich* |
|  | Ran Fridrich |
|  | Chief Executive Officer and Director |

---

Dated: June 30, 2025

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Ellomay Capital Reports Results for the Three Months Ended March 31, 2025**

Tel-Aviv, Israel, Jun. 30, 2025 (GLOBE NEWSWIRE) -- **Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company")**, a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today reported its unaudited interim consolidated financial results for the three month period ended March 31, 2025.

**Financial Highlights**

● Total assets as of March 31, 2025 amounted to approximately €721.2 million, compared to total assets as of December 31, 2024 of approximately €677.3 million.

● Revenues for the three months ended March 31, 2025 were approximately €8.9 million, compared to revenues of approximately €8.2 million for the three months ended March 31, 2024.

● Profit for the three months ended March 31, 2025 was approximately €6.8 million, compared to loss of approximately €4.9 million for the three months ended March 31, 2024.

● EBITDA for the three months ended March 31, 2025 was approximately €2.9 million, compared to EBITDA of approximately €1.6 million for the three months ended March 31, 2024. See below under "Use of Non-IFRS Financial Measures" for additional disclosure concerning EBITDA.

**Financial Overview for the Three Months Ended March 31, 2025**

● Revenues were approximately €8.9 million for the three months ended March 31, 2025, compared to approximately €8.2 million for the three months ended March 31, 2024. The increase in revenues mainly results from revenues generated from our 19.8 MW and 18.1 MW Italian solar facilities that were connected to the grid in February-May 2024 and in January 2025, respectively.

● Operating expenses were approximately €4.6 million for the three months ended March 31, 2025, compared to approximately €4.6 million for the three months ended March 31, 2024. Depreciation and amortization expenses were approximately €4.2 million for the three months ended March 31, 2025, compared to approximately €4.1 million for the three months ended March 31, 2024.

● Project development costs were approximately €1 million for the three months ended March 31, 2025, compared to approximately €1.4 million for the three months ended March 31, 2024. The decrease in project development costs is mainly due to projects that reached "ready to build" status, which results in the commencement of the capitalization of expenses related to such projects into fixed assets.

● General and administrative expenses were approximately €1.7 million for the three months ended March 31, 2025, compared to approximately €1.6 million for the three months ended March 31, 2024.

● The Company's share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €1.2 million for the three months ended March 31, 2025, compared to approximately €1.3 million for the three months ended March 31, 2024.

● Other income was approximately €0.2 million for the three months ended March 31, 2025, compared to €0 for the three months ended March 31, 2024. The income during the three months ended March 31, 2025 was recognized based on insurance compensation in connection with the fire near the Talasol and Ellomay Solar facilities in Spain in July 2024 due to loss of income in 2025.

● Financing income, net, were approximately €7.2 million for the three months ended March 31, 2025, compared to financing expenses of approximately €3.3 million for the three months ended March 31, 2024. The change in financing expenses, net, was mainly attributable to higher income resulting from exchange rate differences that amounted to approximately €10.7 million for the three months ended March 31, 2025, compared to loss from exchange rate differences of approximately €0.6 million for the three months ended March 31, 2024, an aggregate change of approximately €11.3 million. The exchange rate differences were mainly recorded in connection with the New Israeli Shekel ()"**NIS**") cash and cash equivalents and the Company's NIS denominated debentures and were caused by the 5.9% devaluation of the NIS against the euro during the three months ended March 31, 2025, compared to a revaluation of 0.8% during the three months ended March 31, 2024. The increase in financing income for the three months ended March 31, 2025 was partially offset by an increase in financing expenses of approximately €0.9 million in connection with derivatives and warrants for the three months ended March 31, 2025, compared to the three months ended March 31, 2024.

● Tax benefit was approximately €0.9 million for the three months ended March 31, 2025, compared to tax benefit of approximately €0.8 million for the three months ended March 31, 2024.

● Loss from discontinued operation (net of tax) was €0 for the three months ended March 31, 2025, compared to a loss from discontinued operation (net of tax) of approximately €0.3 million for the three months ended March 31, 2024.

● Profit for the three months ended March 31, 2025 was approximately €6.8 million, compared to loss of approximately €4.9 million for the three months ended March 31, 2024.

● Total other comprehensive loss was approximately €4.9 million for the three months ended March 31, 2025, compared to total other comprehensive income of approximately €12 million in the three months ended March 31, 2024. The change in total other comprehensive income (loss) is primarily as the result of foreign currency translation adjustments due to the change in the NIS/euro exchange rate and by changes in fair value of cash flow hedges, including a material decrease in the fair value of the liability resulting from the financial power swap that covers approximately 80% of the output of the Talasol solar plant (the "**Talasol PPA** "). The Talasol PPA experienced a high volatility due to the substantial change in electricity prices in Europe. In accordance with hedge accounting standards, the changes in the Talasol PPA's fair value are recorded in the Company's shareholders' equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company's consolidated net profit/loss or the Company's consolidated cash flows.

● Total comprehensive income was approximately €1.9 million for the three months ended March 31, 2025, compared to total comprehensive income of approximately €7.1 million for the three months ended March 31, 2024.

● EBITDA was approximately €2.9 million for the three months ended March 31, 2025, compared to approximately €1.6 million for the three months ended March 31, 2024.

● Net cash from operating activities was approximately €0.3 million for the three months ended March 31, 2025, compared to approximately €1.2 million for the three months ended March 31, 2024.

● On February 16, 2025, the Company issued in an Israeli public offering an aggregate principal amount of NIS 214,479,000 of newly issued Series G Debentures, due December 31, 2032. The net proceeds of the offering, net of related expenses such as consultancy fee and commissions, were approximately NIS 211.7 million (approximately €56.7 million as of the issuance date).

**CEO Review for the First Quarter of 2025**

**In the first quarter, the Company's revenues amounted to €8.9 million, an increase of approximately 9% in revenues compared to the corresponding quarter last year. These revenues do not include the Company's share of Dorad's revenues. The Company presented an increase of approximately 81% in EBITDA compared to the corresponding quarter last year (€2.9 million compared to €1.6 million in the corresponding quarter last year). The Company's first quarter is a winter quarter and is characterized by low production and revenues compared to the other quarters of the year.** 

**In the first half of 2025, the Company recorded significant progress in the start of construction and connection to the grid of new projects, which are expected to contribute to revenue growth in the near future.**

**In Italy** – Financing agreements were signed for solar projects with a total capacity of 198 MW (of which 38 MW are already connected to the electricity grid), and a transaction was signed and consummated with Clal Insurance to enter as a partner (49%) in the aforementioned 198 MW. Construction work on 160 MW has begun and construction is progressing as planned. The remainder of the portfolio held by the Company (100%) is approximately 264 MW solar, of which 124 MW have received construction permits and the rest are expected to receive permits in the near future. These 264 MW are scheduled to begin construction in the last quarter of 2026.

**In the US** – The Company is advancing additional solar projects with a capacity of approximately 50 MW (beyond the existing portfolio (49 MW) which has completed construction), which are expected to begin construction during 2025. The intention is that these projects will be able to enjoy the full tax benefit currently in effect. The addition of battery storage to each of the projects is also under planning.

**In the Netherlands** – the Company received, after March 31, 2025, a license to increase production at the GGG facility by 64%. Licenses to increase production at the two additional facilities are in advanced stages. The new regulation for the obligation to blend green gas with fossil gas will commence according to the law in January 2027 (a delay of one year), but the targets for the first year have increased. Agreements have been signed for the sale of green certificates issued under the new regulation at a price of approximately €1 per certificate. The blending obligation is expected to significantly increase the profitability of operations in the Netherlands at current production capacity. The expected increase in production capacity from 16 million cubic meters of gas per year to around 24 million cubic meters of gas per year is expected to add significantly beyond that.

**In Israel** – the Company is in negotiations with the Israeli Electricity Authority for compensation for delays and war damage to the Manara project. Ellomay Luzon (50% owned) provided a notice of exercise of its right of first refusal on the Zorlu-Phoenix transaction for the sale of Dorad's shares. Ellomay Luzon and another shareholder exercised their right of first refusal with respect to all of the shares offered (15% of Dorad's shares), and, subject to the timely fulfillment of the conditions to closing, Ellomay Luzon and the other shareholder are expected to share these shares in equal parts.

**In Spain** – The Company's development activity in Spain focuses on battery storage, due to the high volatility in electricity prices in Spain, which stems from an excess of renewable energy during the transition seasons and causes damage to the stability of the grid. In the Company's assessment, the solution is a significant increase in storage capacity, which is currently at very low levels in Spain. Regulation in Spain is also starting to move in this direction.

**Use of Non-IFRS Financial Measures**

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 17 of this press release.

**About Ellomay Capital Ltd.**

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay focuses its business in the renewable energy and power sectors in Europe, USA and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

● Approximately 335.9 MW of operating solar power plants in Spain (including a 300 MW solar plant in owned by Talasol, which is 51% owned by the Company) and 51% of approximately 38 MW of operating solar power plants in Italy;

● 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 850MW, representing about 6%-8% of Israel's total current electricity consumption;

● Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million Nm3 per year, respectively;

● 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;

● 51% of solar projects in Italy with an aggregate capacity of 160 MW that commenced construction processes;

● Solar projects in Italy with an aggregate capacity of 134 MW that have reached "ready to build" status; and

● Solar projects in the Dallas Metropolitan area, Texas, USA with an aggregate capacity of approximately 27 MW that are connected to the grid and additional 22 MW that are awaiting connection to the grid.

For more information about Ellomay, visit http://www.ellomay.com.

**Information Relating to Forward-Looking Statements**

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including changes in electricity prices and demand, regulatory changes increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, the impact of the war and hostilities in Israel and Gaza and between Israel and Iran, the impact of the continued military conflict between Russia and Ukraine, technical and other disruptions in the operations or construction of the power plants owned by the Company, inability to obtain the financing required for the development and construction of projects, inability to advance the expansion of Dorad, increases in interest rates and inflation, changes in exchange rates, delays in development, construction, or commencement of operation of the projects under development, failure to obtain permits - whether within the set time frame or at all, climate change, and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

<u>Contact:</u> 

Kalia Rubenbach (Weintraub)

CFO

Tel: +972 (3) 797-1111

Email: hilai@ellomay.com

Ellomay Capital Ltd. and its Subsidiaries

**Condensed Consolidated Statements of Financial Position**

---

| | | | |
|:---|:---|:---|:---|
|  | **March 31,**<br>**2025** | **December 31,**<br>**2024** | **March 31,**<br>**2025** |
|  | **Unaudited** | **Audited** | **Unaudited** |
|  | **€ in thousands** | **€ in thousands** | **Convenience<br> Translation<br> into US$ in thousands\*** |
| **Assets** |  |  |  |
| **Current assets:** |  |  |  |
| Cash and cash equivalents | **35148** | 41134 | **38021** |
| Short term deposits | **36301** |  | **39268** |
| Restricted cash | **656** | 656 | **710** |
| Intangible asset from green certificates | **195** | 178 | **211** |
| Trade and revenue receivables | **5911** | 5393 | **6394** |
| Other receivables | **15518** | 15341 | **16786** |
| Derivatives asset short-term | **650** | 146 | **703** |
|  | **94379** | 62848 | **102093** |
| **Non-current assets** |  |  |  |
| Investment in equity accounted investee | **40107** | 41324 | **43385** |
| Advances on account of investments | **547** | 547 | **592** |
| Fixed assets | **487100** | 482747 | **526914** |
| Right-of-use asset | **41276** | 34315 | **44650** |
| Restricted cash and deposits | **15569** | 17052 | **16842** |
| Deferred tax | **8525** | 9039 | **9222** |
| Long term receivables | **13882** | 13411 | **15017** |
| Derivatives | **19855** | 15974 | **21478** |
|  | **626861** | 614409 | **678100** |
| **Total assets** | **721240** | 677257 | **780193** |
| **Liabilities and Equity** |  |  |  |
| **Current liabilities** |  |  |  |
| Current maturities of long-term bank loans | **20761** | 21316 | **22458** |
| Current maturities of other long-term loans | **5866** | 5866 | **6345** |
| Current maturities of debentures | **47233** | 35706 | **51094** |
| Trade payables | **9928** | 8856 | **10738** |
| Other payables | **8913** | 10896 | **9642** |
| Current maturities of derivatives | **40** | 1875 | **43** |
| Current maturities of lease liabilities | **733** | 714 | **793** |
| Warrants | **1740** | 1446 | **1882** |
|  | **95214** | 86675 | **102995** |
| **Non-current liabilities** |  |  |  |
| Long-term lease liabilities | **32673** | 25324 | **35344** |
| Long-term bank loans | **242177** | 245866 | **261972** |
| Other long-term loans | **29578** | 30448 | **31996** |
| Debentures | **186691** | 155823 | **201951** |
| Deferred tax | **2652** | 2609 | **2869** |
| Other long-term liabilities | **950** | 939 | **1028** |
| Derivatives | **135** | 288 | **146** |
|  | **494856** | 461297 | **535306** |
| **Total liabilities** | **590070** | 547972 | **638301** |
| **Equity** |  |  |  |
| Share capital | **25613** | 25613 | **27707** |
| Share premium | **86275** | 86271 | **93327** |
| Treasury shares | **(1736)** | (1736) | (1878) |
| Transaction reserve with non-controlling Interests | **5697** | 5697 | **6163** |
| Reserves | **7381** | 14338 | **7984** |
| Accumulated deficit | **(3567)** | (11561) | **(3859)** |
| Total equity attributed to shareholders of the Company | **119663** | 118622 | **129444** |
| Non-Controlling Interest | **11507** | 10663 | **12448** |
| **Total equity** | **131170** | 129285 | **141892** |
| **Total liabilities and equity** | **721240** | 677257 | **780193** |

---

\* Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)

Ellomay Capital Ltd. and its Subsidiaries

**Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended March 31,** | **For the three months ended March 31,** | | |
|  | **2025** | **2024** | **For the year ended December 31,**<br>**2024** | **For the three months ended <br> March 31,**<br>**2025** |
|  | **Unaudited** | **Unaudited** | **Audited** | **Unaudited** |
|  | **€ in thousands (except per share data)** | **€ in thousands (except per share data)** | **€ in thousands (except per share data)** | **Convenience Translation into US$\*** |
| Revenues | **8860** | 8243 | 40467 | **9584** |
| Operating expenses | **(4627)** | (4563) | (19803) | **(5005)** |
| Depreciation and amortization expenses | **(4238)** | (4055) | (15887) | **(4584)** |
| **Gross profit (loss)** | **(5)** | (375) | 4777 | **(5)** |
| Project development costs | **(1045)** | (1415) | (4101) | **(1130)** |
| General and administrative expenses | **(1662)** | (1620) | (6063) | **(1798)** |
| Share of profits of equity accounted investee | **1189** | 1286 | 11062 | **1286** |
| Other income | **198** | - | 3409 | **214** |
| **Operating profit (loss)** | **(1325)** | (2124) | 9084 | **(1433)** |
| Financing income | **11483** | 631 | 2495 | **12422** |
| Financing income (expenses) in connection with derivatives and warrants, net | **(376)** | 536 | 1140 | **(407)** |
| Financing expenses in connection with projects finance | **(1375)** | (1501) | (6190) | **(1487)** |
| Financing expenses in connection with debentures | **(1741)** | (1711) | (6641) | **(1883)** |
| Interest expenses on minority shareholder loan | **(476)** | (554) | (2144) | **(515)** |
| Other financing expenses | **(294)** | (713) | (8311) | **(318)** |
| Financing income (expenses), net | **7221** | (3312) | (19651) | **7812** |
| **Profit (loss) before taxes on income** | **5896** | (5436) | (10567) | **6379** |
| Tax benefit | **922** | 828 | 1424 | **997** |
| **Profit (loss) from continuing operations** | **6818** | (4608) | (9143) | **7376** |
| **Profit (loss) from discontinued operation (net of tax)** | **-** | (312) | 137 | **-** |
| **Profit (loss) for the period** | **6818** | (4920) | (9006) | **7376** |
| **Profit (loss) attributable to:** |  |  |  |  |
| Owners of the Company | **7994** | (3613) | (6524) | **8647** |
| Non-controlling interests | **(1176)** | (1307) | (2482) | **(1271)** |
| **Profit (loss) for the period** | **6818** | (4920) | (9006) | **7376** |
| **Other comprehensive income items** |  |  |  |  |
| **That after initial recognition in comprehensive income were or will be transferred to profit or loss:** |  |  |  |  |
| Foreign currency translation differences for foreign operations | **(9538)** | 1124 | 8007 | **(10318)** |
| Foreign currency translation differences for foreign operations that were recognized in profit or loss | **-** |  | 255 |  |
| Effective portion of change in fair value of cash flow hedges | **4264** | 10461 | 5631 | **4613** |
| Net change in fair value of cash flow hedges transferred to profit or loss | **337** | 457 | (813) | **365** |
| Total other comprehensive income | **(4937)** | 12042 | 13080 | **(5340)** |
| **Total other comprehensive income (loss) attributable to:** |  |  |  |  |
| Owners of the Company | **(6957)** | 6656 | 10039 | **(7526)** |
| Non-controlling interests | **2020** | 5386 | 3041 | **2186** |
| **Total other comprehensive income (loss)** | **(4937)** | 12042 | 13080 | **(5340)** |
| **Total comprehensive income for the period** | **1881** | 7122 | 4074 | **2036** |
| **Total comprehensive income for the period attributable to:** |  |  |  |  |
| Owners of the Company | **1037** | 3043 | 3515 | **1121** |
| Non-controlling interests | **844** | 4079 | 559 | **915** |
| **Total comprehensive income for the period** | **1881** | 7122 | 4074 | **2036** |

---

\* Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)

Ellomay Capital Ltd. and its Subsidiaries

**Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss) (cont'd)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended<br> March 31,** | **For the three months ended<br> March 31,** | | |
|  | **2025** | **2024** | **For the year ended<br> December 31,**<br>**2024** | **For the three months ended<br> March 31,**<br>**2025** |
|  | **Unaudited** | **Unaudited** | **Audited** | **Unaudited** |
|  | **€ in thousands (except per share data)** | **€ in thousands (except per share data)** | **€ in thousands (except per share data)** | **Convenience Translation into US$\*** |
| **Basic profit (loss) per share** | **0.62** | (0.28) | (0.51) | **0.67** |
| **Diluted profit (loss) per share** | **0.62** | (0.28) | (0.51) | **0.67** |
| **Basic profit (loss) per share continuing operations** | **0.62** | (0.31) | (0.52) | **0.67** |
| **Diluted profit (loss) per share continuing operations** | **0.62** | (0.31) | (0.52) | **0.67** |
| **Basic profit (loss) per share discontinued operation** | **-** | (0.02) | 0.01 | **-** |
| **Diluted profit (loss) per share discontinued operation** | **-** | (0.02) | 0.01 | **-** |

---

\* Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)

Ellomay Capital Ltd. and its Subsidiaries

**Condensed Consolidated Interim Statements of Changes in Equity**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | | |
|  | <br>**Share capital** | <br>**Share premium** | **Accumulated Deficit** | **Treasury shares** | **Translation reserve from**<br> **foreign operations** | **Hedging Reserve** | **Interests Transaction reserve with**<br> **non-controlling Interests** | **Total** | <br>**Non- controlling Interests** | <br>**Total Equity** |
|  | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** |
| **For the three months **ended March 31, 2025 (unaudited):** |  |  |  |  |  |  |  |  |  |  |
| **Balance as at January 1, 2025** | 25613 | 86271 | (11561) | (1736) | 8446 | 5892 | 5697 | 118622 | 10663 | 129285 |
| **Profit for the period** | **-** | **-** | **7994** | **-** | **-** | **-** | **-** | **7994** | **(1176)** | **6818** |
| **Other comprehensive income for the period** | **-** | **-** | **-** | **-** | **(9329)** | **2372** | **-** | **(6957)** | **2020** | **(4937)** |
| **Total comprehensive income for the period** | **-** | **-** | **7994** | **-** | **(9329)** | **2372** | **-** | **1037** | **844** | **1881** |
| **Transactions with owners of the Company, recognized directly in equity:** |  |  |  |  |  |  |  |  |  |  |
| **Share-based payments** | **-** | **4** | **-** | **-** | **-** | **-** | **-** | **4** | **-** | **4** |
| **Balance as at March 31, 2025** | **25613** | **86275** | **(3567)** | **(1736)** | **(883)** | **8264** | **5697** | **119663** | **11507** | **131170** |
| For the three months ended March 31, 2024\* (unaudited): |  |  |  |  |  |  |  |  |  |  |
| Balance as at January 1, 2024 | 25613 | 86159 | (5037) | (1736) | 385 | 3914 | 5697 | 114995 | 10104 | 125099 |
| Loss for the period |  |  | (3613) |  |  |  |  | (3613) | (1307) | (4920) |
| Other comprehensive income for the period | - | - | - | - | 1088 | 5568 | - | 6656 | 5386 | 12042 |
| Total comprehensive income (loss) for the period |  |  | (3613) |  | 1088 | 5568 |  | 3043 | 4079 | 7122 |
| Transactions with owners of the Company, recognized directly in equity: |  |  |  |  |  |  |  |  |  |  |
| Share-based payments | - | 30 | - | - | - | - | - | 30 | - | 30 |
| Balance as at March 31, 2024 | 25613 | 86189 | (8650) | (1736) | 1473 | 9482 | 5697 | 118068 | 14183 | 132251 |

---

Ellomay Capital Ltd. and its Subsidiaries

**Condensed Consolidated Interim Statements of Changes in Equity (cont'd)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | | |
|  |<br>**Share capital** |<br>**Share premium** | <br>**Accumulated Deficit** | <br>**Treasury shares** | **Translation reserve from**<br> **foreign operations** | <br>**Hedging Reserve** | **Interests Transaction reserve with**<br> **non-controlling Interests** | <br>**Total** |<br>**Non- controlling Interests** |<br>**Total Equity** |
|  | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** |
| **For the year ended** | | | | | | | | | | |
| &nbsp;&nbsp;&nbsp;**December 31, 2024 (audited):** | | | | | | | | | | |
| **Balance as at January 1, 2024** | 25613 | 86159 | (5037) | (1736) | 385 | 3914 | 5697 | 114995 | 10104 | 125099 |
| **Loss for the year** |  |  | (6524) |  |  |  |  | (6524) | (2482) | (9006) |
| **Other comprehensive income for the year** | - | - | - | - | 8061 | 1978 | - | 10039 | 3041 | 13080 |
| **Total comprehensive income (loss) for the year** |  |  | (6524) |  | 8061 | 1978 |  | 3515 | 559 | 4074 |
| **Transactions with owners of the Company, recognized directly in equity:** |  |  |  |  |  |  |  |  |  |  |
| **Share-based payments** | - | 112 | - | - | - | - | - | 112 | - | 112 |
| **Balance as at December 31, 2024** | 25613 | 86271 | (11561) | (1736) | 8446 | 5892 | 5697 | 118622 | 10663 | 129285 |

---

Ellomay Capital Ltd. and its Subsidiaries

**Condensed Consolidated Interim Statements of Changes in Equity (cont'd)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | **Attributable to shareholders of the Company** | | |
|  |<br>**Share capital** |<br>**Share premium** | <br>**Accumulated Deficit** | <br>**Treasury shares** | **Translation reserve from**<br> **foreign operations** | <br>**Hedging Reserve** | **Interests Transaction reserve with**<br> **non-controlling Interests** | <br>**Total** |<br>**Non- controlling Interests** |<br>**Total Equity** |
|  | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** | **Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)** |
| **For the three months** | | | | | | | | | | |
| &nbsp;&nbsp;&nbsp;**ended March 31, 2025 (unaudited):** | | | | | | | | | | |
| **Balance as at January 1, 2025** | **27707** | **93323** | **(12506)** | **(1878)** | **9136** | **6374** | **6163** | **128319** | **11533** | **139852** |
| **Loss for the period** | **-** | **-** | **8647** | **-** | **-** | **-** | **-** | **8647** | **(1271)** | **7376** |
| **Other comprehensive income for the period** | **-** | **-** | **-** | **-** | **(10092)** | **2566** | **-** | **(7526)** | **2186** | **(5340)** |
| **Total comprehensive income for the period** | **-** | **-** | **8647** | **-** | **(10092)** | **2566** | **-** | **1121** | **915** | **2036** |
| **Transactions with owners of the Company, recognized directly in equity:** |  |  |  |  |  |  |  |  |  |  |
| **Share-based payments** | **-** | **4** | **-** | **-** | **-** | **-** | **-** | **4** | **-** | **4** |
| **Balance as at March 31, 2025** | **27707** | **93327** | **(3859)** | **(1878)** | **(956)** | **8940** | **6163** | **129444** | **12448** | **141892** |

---

Ellomay Capital Ltd. and its Subsidiaries

**Condensed Consolidated Interim Statements of Cash Flow**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended March 31,** | **For the three months ended March 31,** | | |
|  | **2025** | **2024** | **For the year ended December 31,**<br>**2024** | **For the three months ended March 31,**<br>**2025** |
|  | **Unaudited** | **Unaudited** | **Audited** | **Unaudited** |
|  | <br>**€ in thousands** | <br>**€ in thousands** | <br>**€ in thousands** | **Convenience Translation into US$\*** |
| **Cash flows from operating activities** |  |  |  |  |
| Profit (loss) for the period | **6818** | (4920) | (9006) | **7376** |
| <u>Adjustments for:</u> |  |  |  |  |
| Financing expenses (income), net | **(7221)** | 3167 | 19247 | **(7812)** |
| Loss from settlement of derivatives contract | **-** |  | 316 | **-** |
| Impairment losses on assets of disposal groups classified as held-for-sale | **-** | 601 | 405 | **-** |
| Depreciation and amortization expenses | **4238** | 4084 | 15935 | **4584** |
| Share-based payment transactions | **4** | 30 | 112 | **4** |
| Share of profit of equity accounted investees | **(1189)** | (1286) | (11062) | **(1286)** |
| Payment of interest on loan from an equity accounted investee | **-** |  |  | **-** |
| Change in trade receivables and other receivables | **6178** | (2342) | (8824) | **6683** |
| Change in other assets | **(496)** |  | 3770 | **(537)** |
| Change in receivables from concessions project | **-** | 315 | 793 | **-** |
| Change in trade payables | **1267** | (68) | (31) | **1371** |
| Change in other payables | **(5358)** | 2796 | 4455 | **(5796)** |
| Tax benefit | **(922)** | (805) | (1429) | **(997)** |
| Income taxes refund (paid) | **-** | 564 | 623 | **-** |
| Interest received | **351** | 907 | 2537 | **380** |
| Interest paid | **(3408)** | (1892) | (9873) | **(3687)** |
|  | **(6556)** | 6071 | 16974 | **(7093)** |
| Net cash from operating activities | **262** | 1151 | 7968 | **283** |
| **Cash flows from investing activities** |  |  |  |  |
| Acquisition of fixed assets | **(18550)** | (9020) | (72922) | **(20066)** |
| Interest paid capitalized to fixed assets | **(876)** |  | (2515) | **(948)** |
| Proceeds from sale of investments | **-** |  | 9267 | **-** |
| Advances on account of investments | **-** |  | (163) | **-** |
| Proceeds from advances on account of investments | **-** |  | 514 | **-** |
| Investment in settlement of derivatives, net | **-** | 14 | (316) | **-** |
| Proceed from restricted cash, net | **1307** | 1153 | 689 | **1414** |
| Proceeds from investment in short-term deposits | **(39132)** | (28) | 1004 | **(42331)** |
| **Net cash used in investing activities** | **(57251)** | (7881) | (64442) | **(61931)** |
| **Cash flows from financing activities** |  |  |  |  |
| Issuance of warrants | **-** | 3735 | 2449 | **-** |
| Cost associated with long term loans | **(658)** | (638) | (2567) | **(712)** |
| Payment of principal of lease liabilities | **(372)** | (299) | (2941) | **(402)** |
| Proceeds from long-term loans | **306** | 380 | 19482 | **331** |
| Repayment of long-term loans | **(1792)** | (2357) | (11776) | **(1938)** |
| Repayment of debentures | **--** |  | (35845) | **-** |
| Proceeds from issuance of debentures, net | **56729** | 36450 | 74159 | **61366** |
| **Net cash from financing activities** | **54213** | 37271 | 42961 | **58645** |
| Effect of exchange rate fluctuations on cash and cash equivalents | **(3210)** | 1667 | **3092** | **(3472)** |
| Increase (decrease) in cash and cash equivalents | **(5986)** | 32208 | (10421) | **(6475)** |
| Cash and cash equivalents at the beginning of year | **41134** | 51555 | 51127 | **44496** |
| Cash from disposal groups classified as held-for-sale | **-** | (1041) | 428 | **-** |
| **Cash and cash equivalents at the end of the period** | **35148** | 82722 | 41134 | **38021** |

---

\* Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)

Ellomay Capital Ltd. and its Subsidiaries

**Operating Segments**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Spain** | **Spain** | **Spain** | | | | | | | |
|  |<br>**Italy** | | | |<br>**USA** |<br>**Netherlands** | **Israel** | **Israel** | | | |
|  | **Solar** | **Subsidized**<br>**Plants** | **28 MV**<br>**Solar** |<br>**Talasol** | **Solar** | **Biogas** | **Dorad** | **Manara** | **Total**<br>**reportable**<br>**segments** |<br>**Reconciliations** |<br>**Total**<br>**consolidated** |
|  | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** |
|  | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** | **€ in thousands** |
| **Revenues** | **945** | **786** | **406** | **3246** | **—** | **3477** | **15061** | **—** | **23921** | **(15061)** | **8860** |
| Operating expenses | **(435)** | **(105)** | **(84)** | **(1024)** | **(305)** | **(3206)** | **(11693)** | **—** | **(16851)** | **12224** | **(4627)** |
| Depreciation expenses | **(225)** | **(229)** | **(252)** | **(2839)** | **—** | **(676)** | **(1268)** | **—** | **(5489)** | **1251** | **(4238)** |
| **Gross profit (loss)** | **313** | **452** | **84** | **(617)** | **(305)** | **(405)** | **2100** | **—** | **1623** | **(1628)** | **(5)** |
| **Adjusted gross profit (loss)** | **313** | **452** | **84** | **(617)** | **(305)** | **(405)** | **2100** | **—** | **1623** | **(1628)** | **(5)** |
| Project development costs |  |  |  |  |  |  |  |  |  |  | **(1045)** |
| General and administrative expenses |  |  |  |  |  |  |  |  |  |  | **(1662)** |
| Share of loss of equity accounted investee |  |  |  |  |  |  |  |  |  |  | **1189** |
| Other income, net |  |  |  |  |  |  |  |  |  |  | **198** |
| **Operating profit** |  |  |  |  |  |  |  |  |  |  | **(1325)** |
| Financing income |  |  |  |  |  |  |  |  |  |  | **11483** |
| Financing income in connection with derivatives and warrants, net |  |  |  |  |  |  |  |  |  |  | **(376)** |
| Financing expenses in connection with projects finance |  |  |  |  |  |  |  |  |  |  | **(1375)** |
| Financing expenses in connection with debentures |  |  |  |  |  |  |  |  |  |  | **(1741)** |
| Interest expenses on minority shareholder loan |  |  |  |  |  |  |  |  |  |  | **(476)** |
| Other financing expenses |  |  |  |  |  |  |  |  |  |  | **(294)** |
| Financing expenses, net |  |  |  |  |  |  |  |  |  |  | **7221** |
| **Loss before taxes on income** |  |  |  |  |  |  |  |  |  |  | **5896** |
| **Segment assets as at March 31, 2025** | **87185** | **13242** | **19475** | **223844** | **60458** | **32801** | **108858** | **180504** | **726366** | **(5126)** | **721240** |

---

Ellomay Capital Ltd. and its Subsidiaries

**Reconciliation of Profit (Loss) to EBITDA**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended March 31,** | **For the three months ended March 31,** | | |
|  | **2025** | **2024** | **For the year ended<br> December 31,**<br>**2024** | **For the three months ended March 31,**<br>**2025** |
|  | **€ in thousands** | **€ in thousands** | **€ in thousands** | **Convenience<br> Translation into US$\*** |
| **Net profit (loss) for the period** | **6818** | (4920) | (9006) | **7376** |
| **Financing expenses (income), net** | **(7221)** | 3312 | 19651 | **(7812)** |
| **Tax benefit** | **(922)** | (828) | (1424) | **(997)** |
| **Depreciation and amortization expenses** | **4238** | 4055 | 15887 | **4584** |
| **EBITDA** | **2913** | 1619 | 25108 | **3151** |

---

\* Convenience translation into US$(exchange rate as at March 31, 2025: euro 1 = US$1.082)

Ellomay Capital Ltd. and its Subsidiaries

**Information for the Company's Debenture Holders**

*Financial Covenants*

Pursuant to the Deeds of Trust governing the Company's Series C, Series D, Series E, Series F and Series G Debentures (together, the "**Debentures**"), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 30, 2025, and below.

*Net Financial Debt*

As of March 31, 2025, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately €170 million (consisting of approximately €303<sup>1</sup> million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €241.4<sup>2</sup> million in connection with (i) the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021), (ii) the Series D Convertible Debentures issuance (in February 2021), (iii) the Series E Secured Debentures issuance (in February 2023), (iv) the Series F Debentures issuance (in January, April, August and November 2024) and (v) the Series G Debentures issuance (in February 2025)), net of approximately €71.4 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €303<sup>3</sup> million of project finance and related hedging transactions of the Company's subsidiaries).

*Discussion concerning Warning Signs*

 

Upon the issuance of the Company's Debentures, the Company undertook to comply with the "hybrid model disclosure requirements" as determined by the Israeli Securities Authority and as described in the Israeli prospectuses published in connection with the public offering of the company's Debentures. This model provides that in the event certain financial "warning signs" exist in the Company's consolidated financial results or statements, and for as long as they exist, the Company will be subject to certain disclosure obligations towards the holders of the Company's Debentures.

One possible "warning sign" is the existence of a working capital deficiency if the Company's Board of Directors does not determine that the working capital deficiency is not an indication of a liquidity problem. In examining the existence of warning signs as of March 31, 2025, the Company's Board of Directors noted the working capital deficiency as of March 31, 2025, in the amount of approximately €0.96 million. The Company's Board of Directors reviewed the Company's financial position, outstanding debt obligations and the Company's existing and anticipated cash resources and uses and determined that the existence of a working capital deficiency as of March 31, 2025, does not indicate a liquidity problem. In making such determination, the Company's Board of Directors noted the following: (i) the execution of the agreement to sell tax credits in connection with the US solar projects, which is expected to contribute approximately $19 million during the next twelve months, (ii) the Company's positive cash flow from operating activities during 2023 and 2024, and (iii) funds received from the investment transaction with Clal Insurance Company Ltd. that was consummated in June 2025.

<sup>1</sup> The amount of short-term and long-term debt from banks and other interest-bearing financial obligations provided above, includes an amount of approximately €4.5 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company's balance sheet.

<sup>2</sup> The amount of the debentures provided above includes an amount of approximately €6.7 million associated costs, which was capitalized and discount or premium and therefore offset from the debentures amount that is recorded in the Company's balance sheet. This amount also includes the accrued interest as at March 31, 2025 in the amount of approximately €0.8 million.

<sup>3</sup> The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).

Ellomay Capital Ltd. and its Subsidiaries

**Information for the Company's Debenture Holders (cont'd)**

 

*Information for the Company's Series C Debenture Holders*

The Deed of Trust governing the Company's Series C Debentures (as amended on June 6, 2022, the "**Series C Deed of Trust**"), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of March 31, 2025, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series C Deed of Trust) was approximately €116.6 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 59.3%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA,<sup>4</sup> was 6.3.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended March 31, 2025:

---

| | |
|:---|:---|
|  | **For the four-quarter period ended March 31, 2025** |
|  | **Unaudited** |
|  | **€ in thousands** |
| Profit for the period | **2274** |
| Financing expenses, net | **9118** |
| Taxes on income | **(1641)** |
| Depreciation and amortization expenses | **16651** |
| Share-based payments | **86** |
| Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | **484** |
| Adjusted EBITDA as defined the Series C Deed of Trust | **26972** |

---

 

The Series C Debentures were fully repaid on June 30, 2025 in accordance with their terms.

<sup>4</sup> The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef solar plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

Ellomay Capital Ltd. and its Subsidiaries

**Information for the Company's Debenture Holders (cont'd)**

 

*Information for the Company's Series D Debenture Holders*

 

The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of March 31, 2025, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €116.6 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 59.3%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA<sup>5</sup> was 6.1.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended March 31, 2025:

---

| | |
|:---|:---|
|  | **For the four-quarter period ended March 31, 2025** |
|  | **Unaudited** |
|  | **€ in thousands** |
| Loss for the period | **2274** |
| Financing expenses, net | **9118** |
| Taxes on income | **(1641)** |
| Depreciation and amortization expenses | **16651** |
| Share-based payments | **86** |
| Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | **484** |
| Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters<sup>6</sup> | **899** |
| Adjusted EBITDA as defined the Series D Deed of Trust | **27871** |

---

<sup>5</sup> The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

<sup>6</sup> The adjustment is based on the results of solar plants in Italy that were connected to the grid and commenced delivery of electricity to the grid during the year ended December 31, 2024 (two plants) and the three months ended March 31, 2025 (one plant). The Company recorded revenues and only direct expenses in connection with these solar plants from the connection to the grid and until PAC (Preliminary Acceptance Certificate – reached with respect to two of the three plants during the fourth quarter of 2024). However, for the sake of caution, the Company included the expected fixed expenses in connection with these solar plants in the calculation of the adjustment.

Ellomay Capital Ltd. and its Subsidiaries

**Information for the Company's Debenture Holders (cont'd)**

*Information for the Company's Series E Debenture Holders*

 

The Deed of Trust governing the Company's Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of March 31, 2025, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series E Deed of Trust) was approximately €116.6 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 59.3%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA<sup>7</sup> was 6.1.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended March 31, 2025:

---

| | |
|:---|:---|
|  | **For the four-quarter period ended March 31, 2025** |
|  | **Unaudited** |
|  | **€ in thousands** |
| Profit for the period | **2274** |
| Financing expenses, net | **9118** |
| Taxes on income | **(1641)** |
| Depreciation and amortization expenses | **16651** |
| Share-based payments | **86** |
| Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | **484** |
| Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters<sup>8</sup> | **899** |
| Adjusted EBITDA as defined the Series E Deed of Trust | **27871** |

---

In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. ("**Ellomay Luzon Energy**")), which were pledged to the holders of the Company's Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.

As of March 31, 2025, the value of the assets pledged to the holders of the Series E Debentures in the Company's books (unaudited) is approximately €40.1 million (approximately NIS 161.3 million based on the exchange rate as of such date).

<sup>7</sup> The term "Adjusted EBITDA" is defined in the Series E Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series E Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series E Deed of Trust). The Series E Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series E Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

<sup>8</sup> The adjustment is based on the results of solar plants in Italy that were connected to the grid and commenced delivery of electricity to the grid during the year ended December 31, 2024 (two plants) and the three months ended March 31, 2025 (one plant). The Company recorded revenues and only direct expenses in connection with these solar plants from the connection to the grid and until PAC (Preliminary Acceptance Certificate – reached with respect to two of the three plants during the fourth quarter of 2024). However, for the sake of caution, the Company included the expected fixed expenses in connection with these solar plants in the calculation of the adjustment.

Ellomay Capital Ltd. and its Subsidiaries

**Information for the Company's Debenture Holders (cont'd)**

*Information for the Company's Series F Debenture Holders*

 

The Deed of Trust governing the Company's Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of March 31, 2025, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series F Deed of Trust) was approximately €115.9 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 59.4%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA<sup>9</sup> was 6.1.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series F Deed of Trust) for the four-quarter period ended March 31, 2025:

---

| | |
|:---|:---|
|  | **For the four-quarter period ended March 31, 2025** |
|  | **Unaudited** |
|  | **€ in thousands** |
| Profit for the period | **2274** |
| Financing expenses, net | **9118** |
| Taxes on income | **(1641)** |
| Depreciation and amortization expenses | **16651** |
| Share-based payments | **86** |
| Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | **484** |
| Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters<sup>10</sup> | **899** |
| Adjusted EBITDA as defined the Series F Deed of Trust | **27871** |

---

<sup>9</sup> The term "Adjusted EBITDA" is defined in the Series F Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series F Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series F Deed of Trust). The Series F Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series F Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."

<sup>10</sup> The adjustment is based on the results of solar plants in Italy that were connected to the grid and commenced delivery of electricity to the grid during the year ended December 31, 2024 (two plants) and the three months ended March 31, 2025 (one plant). The Company recorded revenues and only direct expenses in connection with these solar plants from the connection to the grid and until PAC (Preliminary Acceptance Certificate – reached with respect to two of the three plants during the fourth quarter of 2024). However, for the sake of caution, the Company included the expected fixed expenses in connection with these solar plants in the calculation of the adjustment.

Ellomay Capital Ltd. and its Subsidiaries

**Information for the Company's Debenture Holders (cont'd)**

*Information for the Company's Series G Debenture Holders*

 

The Deed of Trust governing the Company's Series G Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series G Deed of Trust is a cause for immediate repayment. As of March 31, 2025, the Company was in compliance with the financial covenants set forth in the Series G Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series G Deed of Trust) was approximately €115.9 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 59.4%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA<sup>11</sup> was 6.1.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series G Deed of Trust) for the four-quarter period ended March 31, 2025:

---

| | |
|:---|:---|
|  | **For the four-quarter period ended March 31, 2025** |
|  | **Unaudited** |
|  | **€ in thousands** |
| Profit for the period | **2274** |
| Financing expenses, net | **9118** |
| Taxes on income | **(1641)** |
| Depreciation and amortization expenses | **16651** |
| Share-based payments | **86** |
| Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model | **484** |
| Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters<sup>12</sup> | **899** |
| Adjusted EBITDA as defined the Series G Deed of Trust | **27871** |

---

<sup>11</sup> The term "Adjusted EBITDA" is defined in the Series G Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series G Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series G Deed of Trust). The Series G Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series G Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."

<sup>12</sup> The adjustment is based on the results of solar plants in Italy that were connected to the grid and commenced delivery of electricity to the grid during the year ended December 31, 2024 (two plants) and the three months ended March 31, 2025 (one plant). The Company recorded revenues and only direct expenses in connection with these solar plants from the connection to the grid and until PAC (Preliminary Acceptance Certificate – reached with respect to two of the three plants during the fourth quarter of 2024). However, for the sake of caution, the Company included the expected fixed expenses in connection with these solar plants in the calculation of the adjustment.